Glial markers such as GFAP have also been proposed as potential biomarkers, given that neuroinflammation is a hallmark of early gastrointestinal dysfunction in PD (Clairembault et al. 2014; Devos et al. 2013). This evidence concerns the gene GFAP and Parkinson disease.